Início › Leucemia Mieloide Aguda › Kansas › Overland Park
Ensaios clínicos de Leucemia Mieloide Aguda em Overland Park, KS
11 estudos para Leucemia Mieloide Aguda estão buscando participantes em locais em Overland Park e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RecrutandoFase 2
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · a 3 mi de distância
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
RecrutandoFase 2
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · a 3 mi de distância
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
RecrutandoFase 2
- University of Kansas Clinical Research Center, Fairway · a 3 mi de distância
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RecrutandoFase 2
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · a 3 mi de distância
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
RecrutandoFase 2
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · a 3 mi de distância
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
RecrutandoFase 3
- US-Kansas City KS-KUMC, Fairway · a 3 mi de distância
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
RecrutandoFase 1
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · a 3 mi de distância
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RecrutandoFase 1
- The University of Kansas Medical Center Research Institute, Fairway · a 3 mi de distância
APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML
RecrutandoFase 1
- University of Kansas, Fairway · a 3 mi de distância
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
RecrutandoFase 2
- University of Kansas Cancer Center, Fairway · a 3 mi de distância
Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02
RecrutandoFase 1
- University of Kansas Cancer Center, Fairway · a 3 mi de distância
Ensaios de Leucemia Mieloide Aguda em outras cidades
- Houston, TX85 estudos
- New York City, NY51 estudos
- Boston, MA44 estudos
- Seattle, WA41 estudos
- Baldwin Park, CA40 estudos
- Columbus, OH35 estudos
- Philadelphia, PA34 estudos
- Durham, NC33 estudos
- Atlanta, GA31 estudos
- Tampa, FL29 estudos
- Chicago, IL26 estudos
- Portland, OR25 estudos
Outros estudos em Overland Park
- Câncer de Pulmão de Não Pequenas Células16 estudos
- Câncer de Pulmão11 estudos
- Câncer de Mama10 estudos
- Fibrilação Atrial8 estudos
- Câncer Colorretal8 estudos
- Obesidade7 estudos
- Câncer de Pâncreas7 estudos
- Câncer de Próstata7 estudos
- Melanoma6 estudos
- Sobrepeso6 estudos
- Câncer de Ovário6 estudos
- Câncer (todos os tipos)5 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.